Article
Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study.
European heart journal - 1 Apr 2013
Hopewell Jemma C, Parish Sarah, Offer Alison, Link Emma, Clarke Robert, Lathrop Mark, Armitage Jane, Collins Rory
Abstract excerpt
AIMS: Statins reduce LDL cholesterol (LDL-C) and the risk of vascular events, but it remains uncertain whether there is clinically relevant genetic variation in their efficacy. This study of 18 705 individuals aims to identify genetic variants related to the lipid response to simvastatin and assess their impact on vascular risk response. METHODS AND RESULTS: A genome-wide study of the LDL-C and apolipoprotein B...
Topics
Join the communities discussing this publication.
